GAFFX
Price
$77.55
Change
+$0.55 (+0.71%)
Updated
Jun 2 closing price
Net Assets
301.73B
PGBGX
Price
$47.02
Change
+$0.21 (+0.45%)
Updated
May 30 closing price
Net Assets
11.1B
Interact to see
Advertisement

GAFFX vs PGBGX

Header iconGAFFX vs PGBGX Comparison
Open Charts GAFFX vs PGBGXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.55
Change+$0.55 (+0.71%)
VolumeN/A
Net Assets301.73B
Principal Blue Chip R5
Price$47.02
Change+$0.21 (+0.45%)
VolumeN/A
Net Assets11.1B
GAFFX vs PGBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. PGBGX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and PGBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 302B vs. PGBGX (11.1B). GAFFX pays higher dividends than PGBGX: GAFFX (0.65) vs PGBGX (0.00). GAFFX was incepted earlier than PGBGX: GAFFX (8 years) vs PGBGX (9 years). PGBGX (0.85) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. PGBGX (14.70). PGBGX has a lower initial minimum investment than GAFFX: PGBGX (0) vs GAFFX (1000000). PGBGX annual gain was more profitable for investors over the last year : 11.82 vs. GAFFX (9.74). PGBGX return over 5 years is better than : 65.39 vs. GAFFX (48.56).
GAFFXPGBGXGAFFX / PGBGX
Total Expense Ratio0.300.8237%
Annual Report Gross Expense Ratio0.300.8535%
Fund Existence8 years9 years-
Gain YTD3.3974.00485%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets302B11.1B2,721%
Annual Yield % from dividends0.650.00-
Returns for 1 year9.7411.8282%
Returns for 3 years36.5753.3669%
Returns for 5 years48.5665.3974%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTTA0.970.03
+3.19%
Pasithea Therapeutics Corp
BIP33.110.45
+1.38%
Brookfield Infrastructure Partners LP
SMWB7.420.01
+0.13%
Similarweb Ltd
ACRS1.46N/A
N/A
Aclaris Therapeutics
CRNX30.51-0.01
-0.03%
Crinetics Pharmaceuticals